Development of Prototype Filovirus Recombinant Antigen Immunoassays

Background. Throughout the 2014–2015 Ebola outbreak in West Africa, major gaps were exposed in the availability of validated rapid diagnostic platforms, protective vaccines, and effective therapeutic agents. These gaps potentiated the development of prototype rapid lateral flow immunodiagnostic (LFI...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Boisen, Matt L., Oottamasathien, Darin, Jones, Abigail B., Millett, Molly M., Nelson, Diana S., Bornholdt, Zachary A., Fusco, Marnie L., Abelson, Dafna M., Oda, Shun-ichiro, Hartnett, Jessica N., Rowland, Megan M., Heinrich, Megan L., Akdag, Marjan, Goba, Augustine, Momoh, Mambu, Fullah, Mohammed, Baimba, Francis, Gbakie, Michael, Safa, Sadiki, Fonnie, Richard, Kanneh, Lansana, Cross, Robert W., Geisbert, Joan B., Geisbert, Thomas W., Kulakosky, Peter C., Grant, Donald S., Shaffer, Jeffery G., Schieffelin, John S., Wilson, Russell B., Saphire, Erica Ollmann, Branco, Luis M., Garry, Robert F., Khan, S. Humarr, Pitts, Kelly R.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Ebola and Marburg Viruses-Research, Outbreak Management, Epidemiology and Ecology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564556/
https://ncbi.nlm.nih.gov/pubmed/26232440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv353
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares